Search results
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Zacks via Yahoo News· 3 months agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually...
5 Large Drug Stocks to Watch From a Thriving Industry
Zacks via Yahoo News· 1 year agoDrug/biotech companies are likely to see significant advances in innovation in 2023. In the...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo News· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo News· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
Zacks via Yahoo News· 2 years agoThis week, the FDA granted emergency approval to Pfizer PFE and partner BioNTech BNTX and Moderna’s...
Pharma Stock Roundup: FDA Okays PFE & JNJ Drugs, EU Approves ABBV's Migraine Drug
Zacks via Yahoo News· 11 months agoFDA approves Pfizer's (PFE) Elrexfio (elranatamab) for RRMM and J&J's (JNJ) oral combination tablet,...
Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits
Zacks via Yahoo News· 1 year agoPfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals...
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
Zacks via Yahoo News· 1 year agoMerck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ)...
Trending tickers: Ocado | Novartis | Rio Tinto | Morgan Stanley
Yahoo Finance UK· 12 months agoOcado stock jumped more than 15% in early trade in London on Tuesday. Photo: Mike Kemp/In Pictures...
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
Zacks via Yahoo News· 7 months agoThis week, AbbVie ABBV announced a definitive agreement to acquire cancer biotech Immunogen at a...